AB01. Incorporation of N0 stage with insufficient numbers of lymph nodes into N1 stage in the seventh edition of the TNM classification improves prediction of prognosis in gastric cancer—results of a single-institution study of 1,258 Chinese patients
Abstract

AB01. Incorporation of N0 stage with insufficient numbers of lymph nodes into N1 stage in the seventh edition of the TNM classification improves prediction of prognosis in gastric cancer—results of a single-institution study of 1,258 Chinese patients

Bo-Fei Li, Zhi-Wei Zhou

Tumor Hospital Affiliated to Sun Yat-sen University, Guangzhou 510060, China


Objective: This study examined the prognosis of the “node-negative with eLNs ≤15” designation and the additional value of incorporating it into the pN1 designation in the seventh edition N classification.

Methods: From Jan 2000 to Sep 2010, a total of 1,258 gastric cancer patients undergoing radical gastric resection were enrolled. We incorporated node-negative patients with eLNs ≤15 into pN1 and compared this designation with the 7th edition UICC N stage for 3.5-year overall survival by univariate and multivariate analysis. Homogeneity, discriminatory ability, and monotonicity of gradients in hypothetical N stage and UICC N stage were compared using linear trend χ2 likelihood ratio χ2 statistics, and Akaike information criterion (AIC) calculations.

Results: Node-negative patients with eLNs ≤15 had worse survival compared with those with eLNs >15. The hypothetical N stage had higher linear trend and likelihood ratio χ2 scores and smaller AIC values compared with those for the 7th edition N stage, which represented the optimum prognostic stratification.

Conclusions: Node-negative patients with eLNs ≤15 can be considered to be incorporated into the pN1 stage in the 7th edition of the TNM classification.


Cite this abstract as: Li BF, Zhou ZW. Incorporation of N0 stage with insufficient numbers of lymph nodes into N1 stage in the seventh edition of the TNM classification improves prediction of prognosis in gastric cancer—results of a single-institution study of 1,258 Chinese patients. Transl Gastrointest Cancer 2015;4(S1):AB01. doi: 10.3978/j.issn.2224-4778.2015.s001